All Stories

  1. Mass spectrometry analysis of bovine tuberculins - 3R potential in batch potency testing
  2. DNA Meets Protein─Development, Characterization, and Application of Aptamers against Peanut Allergen
  3. Quality control of allergen products with mass spectrometry part I: Positioning within the EU regulatory framework
  4. FcγRIIA-specific DARPins as novel tools in blood cell analysis and platelet aggregation
  5. Publisher Correction: Optimizing the dynamics of protein expression
  6. Identification of a natural ligand of the hazel allergen Cor a 1
  7. Identification of Potential Novel Interacting Partners for Coagulation Factor XIII B (FXIII-B) Subunit, a Protein Associated with a Rare Bleeding Disorder
  8. Optimizing the dynamics of protein expression
  9. Quality and potency profile of eight recombinant isoallergens, largely mimicking total Bet v 1‐specific IgE binding of birch pollen
  10. pH and Heat Resistance of the Major Celery Allergen Api g 1
  11. Dephosphorylation of the HIV-1 restriction factor SAMHD1 is mediated by PP2A-B55α holoenzymes during mitotic exit
  12. Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol
  13. Author Correction: Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo
  14. Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo
  15. Model for Quality Control of Allergen Products with Mass Spectrometry
  16. Mass spectrometry to complement standardization of house dust mite and other complex allergenic extracts
  17. Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes
  18. The conformational IgE epitope profile of soya bean allergen Gly m 4
  19. Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective
  20. Quality Control of Biomedicinal Allergen Products – Highly Complex Isoallergen Composition Challenges Standard MS Database Search and Requires Manual Data Analyses
  21. Epicutaneous immunotherapy with a hypoallergenic Bet v 1 suppresses allergic asthma in a murine model
  22. Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations
  23. Enlarging the Toolbox for Allergen Epitope Definition with an Allergen-Type Model Protein
  24. Analysis of the IgE epitope profile of soybean allergen Gly m 4
  25. Identification of Sola l 4 as Bet v 1 homologous pathogenesis related-10 allergen in tomato fruits
  26. Development of a novel method for identification and quantification of birch pollen allergens in parallel
  27. Find the match! A tool for residue-specific analysis of epitopes in Bet v 1-like allergens
  28. Soybean allergy: IgE epitopes of glycinin (Gly m 6), an important soybean allergen
  29. Peroxiredoxin 6 promotes upregulation of the prion protein (PrP) in neuronal cells of prion-infected mice
  30. SAMHD1-Deficient CD14+ Cells from Individuals with Aicardi-Goutières Syndrome Are Highly Susceptible to HIV-1 Infection
  31. Identification of a Dau c PRPlike protein (Dau c 1.03) as a new allergenic isoform in carrots (cultivar Rodelika)
  32. Generation of a comprehensive panel of crustacean allergens from the North Sea Shrimp Crangon crangon
  33. Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites
  34. Relevance of IgE binding to short peptides for the allergenic activity of food allergens
  35. New frontiers in allergen standardization
  36. Prediction of Extracellular Proteases of the Human Pathogen Helicobacter pylori Reveals Proteolytic Activity of the Hp1018/19 Protein HtrA
  37. High level expression, purification and physico- and immunochemical characterisation of recombinant Pen a 1: A major allergen of shrimp
  38. Expression and characterization of three important panallergens from hazelnut
  39. A critical assessment of allergen component-based in vitro diagnosis in cherry allergy across Europe
  40. Novel isoforms of Pru av 1 with diverging immunoglobulin E binding properties identified by a synergistic combination of molecular biology and proteomics
  41. Development of an in vitro model to reduce allergenicity of sweet cherry (Prunus avium L) by RNA interference (RNAi)